These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35378915)

  • 1. miR-873 and miR-105-2 May Affect the Tumour Microenvironment and are Potential Biomarkers for Lung Adenocarcinoma.
    Zhang H; Liu Y; Xu Z; Chen Q
    Int J Gen Med; 2022; 15():3433-3445. PubMed ID: 35378915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR2 and PTPRC are regulators of tumor microenvironment and potential prognostic biomarkers of lung adenocarcinoma.
    Wei J; Fang D; Zhou W
    Ann Transl Med; 2021 Sep; 9(18):1419. PubMed ID: 34733971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13.
    Wang J; Shi W; Miao Y; Gan J; Guan Q; Ran J
    Bioengineered; 2021 Dec; 12(1):6286-6304. PubMed ID: 34494914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
    Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
    Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma.
    Chen S; Wang C; Su X; Dai X; Li S; Mo Z
    Transl Androl Urol; 2021 Jun; 10(6):2454-2470. PubMed ID: 34295732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
    Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
    Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis.
    Ye G; Liu Y; Huang L; Zhang C; Sheng Y; Wu B; Wu C; Qi Y
    Ann Transl Med; 2021 Aug; 9(16):1298. PubMed ID: 34532435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.
    Gan TQ; Chen WJ; Qin H; Huang SN; Yang LH; Fang YY; Pan LJ; Li ZY; Chen G
    Med Sci Monit; 2017 May; 23():2453-2464. PubMed ID: 28533502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray expression profile of microRNAs in lung adenocarcinoma patients with the Cancer Genome Atlas and its clinical validation.
    Chen G; Xing Y; Peng X; Miao L; Zhao M; Zhou H; Xiao Y
    J BUON; 2020; 25(2):821-827. PubMed ID: 32521873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer.
    Chen B; Gao T; Yuan W; Zhao W; Wang TH; Wu J
    J Cancer; 2019; 10(23):5793-5804. PubMed ID: 31737116
    [No Abstract]   [Full Text] [Related]  

  • 14. BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining.
    Bi KW; Wei XG; Qin XX; Li B
    Front Oncol; 2020; 10():424. PubMed ID: 32351880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of microRNAs as potential biomarkers for lung adenocarcinoma using integrating genomics analysis.
    Peng Z; Pan L; Niu Z; Li W; Dang X; Wan L; Zhang R; Yang S
    Oncotarget; 2017 Sep; 8(38):64143-64156. PubMed ID: 28969058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma: sex differences.
    Fan T; Li C; He J
    Biol Sex Differ; 2021 Dec; 12(1):64. PubMed ID: 34863300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
    Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
    Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.
    Ren ZP; Hou XB; Tian XD; Guo JT; Zhang LB; Xue ZQ; Deng JQ; Zhang SW; Pan JY; Chu XY
    FEBS Open Bio; 2019 Feb; 9(2):315-327. PubMed ID: 30761256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.